Moritz Spangemacher
@moeswisdom.bsky.social
Physician & Researcher @zi_mannheim
Podcast: @gottundloeffel
Podcast: @gottundloeffel
Reposted by Moritz Spangemacher
NY Times Ballot - Best Movies of the Century so far
June 24, 2025 at 12:53 PM
NY Times Ballot - Best Movies of the Century so far
Reposted by Moritz Spangemacher
Reframing Psychedelic Regulation: Tools, not Treatments
In this new article, we propose to regulate psychedelics as psychotherapeutic treatment tools rather than as treatments in their own right.
The use of anesthetics as treatment tools in surgery is a useful analogy.
In this new article, we propose to regulate psychedelics as psychotherapeutic treatment tools rather than as treatments in their own right.
The use of anesthetics as treatment tools in surgery is a useful analogy.
June 16, 2025 at 12:03 PM
Reframing Psychedelic Regulation: Tools, not Treatments
In this new article, we propose to regulate psychedelics as psychotherapeutic treatment tools rather than as treatments in their own right.
The use of anesthetics as treatment tools in surgery is a useful analogy.
In this new article, we propose to regulate psychedelics as psychotherapeutic treatment tools rather than as treatments in their own right.
The use of anesthetics as treatment tools in surgery is a useful analogy.
Reposted by Moritz Spangemacher
Reposted by Moritz Spangemacher
🚨🚨New psychedelics paper out today! 🚨🚨
"Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression."
psychiatryonline.org/doi/10.1176/...
🧵⬇️
"Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression."
psychiatryonline.org/doi/10.1176/...
🧵⬇️
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression | American Journal of Psychiatry
Objective: Psilocybin is an emerging intervention for depression that may be at least as effective as selective serotonin reuptake inhibitors (SSRIs), but effects of the two treatments on the neural c...
psychiatryonline.org
May 7, 2025 at 7:15 PM
🚨🚨New psychedelics paper out today! 🚨🚨
"Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression."
psychiatryonline.org/doi/10.1176/...
🧵⬇️
"Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression."
psychiatryonline.org/doi/10.1176/...
🧵⬇️
Reposted by Moritz Spangemacher
My opinion piece in today’s @nytimes.com . I discuss how clinical neglect of medication-related harms has made RFK Jr’s stance on antidepressants appealing to so many and moving the public conversation in a productive direction requires us to remedy this neglect.
www.nytimes.com/2025/05/03/o...
www.nytimes.com/2025/05/03/o...
Opinion | What Kennedy Gets Right, And Wrong, About Antidepressants (Gift Article)
Harm from these drugs is real. Let’s not cede the conversation to Kennedy.
www.nytimes.com
May 3, 2025 at 1:55 PM
My opinion piece in today’s @nytimes.com . I discuss how clinical neglect of medication-related harms has made RFK Jr’s stance on antidepressants appealing to so many and moving the public conversation in a productive direction requires us to remedy this neglect.
www.nytimes.com/2025/05/03/o...
www.nytimes.com/2025/05/03/o...
Reposted by Moritz Spangemacher
Research is investigating the medicinal applications of #psilocybin, with studies showing how #psychedelics can promote neuronal plasticity.
This ‘fundamental’ study into the effects of #psilocin on human neurons: buff.ly/f7cNemV
This ‘fundamental’ study into the effects of #psilocin on human neurons: buff.ly/f7cNemV
March 23, 2025 at 9:21 AM
Research is investigating the medicinal applications of #psilocybin, with studies showing how #psychedelics can promote neuronal plasticity.
This ‘fundamental’ study into the effects of #psilocin on human neurons: buff.ly/f7cNemV
This ‘fundamental’ study into the effects of #psilocin on human neurons: buff.ly/f7cNemV
Reposted by Moritz Spangemacher
Another null result psychedelic trial. This time looking at LSD microdosing for ADHD. Most interesting is the detail showing most subjects in LSD group correctly guessed they got the psychedelic. BUT their benefits still mostly matched the placebo group.
Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults
This double-blind, placebo-controlled randomized clinical trial determines the safety and efficacy of repeated low doses of lysergic acid diethylamide (LSD) in reducing attention-deficit/hyperactivity...
jamanetwork.com
March 19, 2025 at 5:30 PM
Another null result psychedelic trial. This time looking at LSD microdosing for ADHD. Most interesting is the detail showing most subjects in LSD group correctly guessed they got the psychedelic. BUT their benefits still mostly matched the placebo group.
Reposted by Moritz Spangemacher
A recent study suggests that no dose adjustment of #LSD is necessary in the presence of an SSRI that inhibits CYP2D6. #psychedelics ascpt.onlinelibrary.wiley.com/doi/10.1002/...
Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre‐Administration in a Randomized, Double‐Blind, Cross‐Over Phase I Trial
Psychedelics, such as psilocybin and lysergic acid diethylamide (LSD), are being investigated for the treatment of depressive and anxiety disorders, for which concomitant treatment with selective ser...
ascpt.onlinelibrary.wiley.com
March 1, 2025 at 7:05 PM
A recent study suggests that no dose adjustment of #LSD is necessary in the presence of an SSRI that inhibits CYP2D6. #psychedelics ascpt.onlinelibrary.wiley.com/doi/10.1002/...
This cause is close to my heart - please sign: weact.campact.de/petitions/sc...
Schluss mit dem Angriff auf NGOs und Medien! Keine Zensur durch die CDU!
Nur einen Tag nach der Wahl hat die CDU/CSU-Fraktion eine Anfrage eingereicht, die gezielt NGOs und kritische Medien ins Visier nimmt. Einen Tag zuvor nannte Friedrich Merz Demonstranten gegen Rechts ...
weact.campact.de
February 28, 2025 at 9:48 AM
This cause is close to my heart - please sign: weact.campact.de/petitions/sc...
Reposted by Moritz Spangemacher
Wir alle, Robert, wir alle
February 23, 2025 at 8:18 PM
Wir alle, Robert, wir alle
Reposted by Moritz Spangemacher
Wenig überraschend ist die größte inhaltliche Übereinstimmung der CDU mit einer anderen Partei, die, mit der AfD. Das macht gemeinsames Abstimmen natürlich mindestens verlockend und lässt es ganz natürlich erscheinen.
www.spiegel.de/politik/wahl...
www.spiegel.de/politik/wahl...
February 6, 2025 at 10:22 PM
Wenig überraschend ist die größte inhaltliche Übereinstimmung der CDU mit einer anderen Partei, die, mit der AfD. Das macht gemeinsames Abstimmen natürlich mindestens verlockend und lässt es ganz natürlich erscheinen.
www.spiegel.de/politik/wahl...
www.spiegel.de/politik/wahl...
Reposted by Moritz Spangemacher
First suicide in legal PAT, in Switzerland (first known case out of around 2000). History of delusions could be a red flag, not clear what the previous delusions and how psychosis-like they were. Thanks to the team for publishing this. www.sciencedirect.com/science/arti...
Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report
www.sciencedirect.com
February 2, 2025 at 1:01 PM
First suicide in legal PAT, in Switzerland (first known case out of around 2000). History of delusions could be a red flag, not clear what the previous delusions and how psychosis-like they were. Thanks to the team for publishing this. www.sciencedirect.com/science/arti...
Reposted by Moritz Spangemacher
January 13, 2025 at 2:04 PM
Reposted by Moritz Spangemacher
Glad to be at #ACNP2024 in Phoenix!
On Monday, I will be presenting the results of our episode trial in the session „Psychedelic-assisted Psychotherapy: From preclinical mechanisms to clinical applications“
alongside @fredbarrettphd.bsky.social, @kellietamashiro.bsky.social and Jennifer Mitchell.
On Monday, I will be presenting the results of our episode trial in the session „Psychedelic-assisted Psychotherapy: From preclinical mechanisms to clinical applications“
alongside @fredbarrettphd.bsky.social, @kellietamashiro.bsky.social and Jennifer Mitchell.
December 8, 2024 at 9:13 PM
Glad to be at #ACNP2024 in Phoenix!
On Monday, I will be presenting the results of our episode trial in the session „Psychedelic-assisted Psychotherapy: From preclinical mechanisms to clinical applications“
alongside @fredbarrettphd.bsky.social, @kellietamashiro.bsky.social and Jennifer Mitchell.
On Monday, I will be presenting the results of our episode trial in the session „Psychedelic-assisted Psychotherapy: From preclinical mechanisms to clinical applications“
alongside @fredbarrettphd.bsky.social, @kellietamashiro.bsky.social and Jennifer Mitchell.